08:00 , Jan 4, 2010 |  BC Week In Review  |  Company News

Applied NeuroSolutions, Eli Lilly deal

The companies expanded a 2006 deal to include an additional undisclosed target against Alzheimer's disease. Applied NeuroSolutions will receive an upfront payment of $750,000 for the deal expansion and is eligible for an additional $25.5...
07:00 , Sep 7, 2009 |  BC Week In Review  |  Company News

Applied NeuroSolutions management update

Applied NeuroSolutions Inc. (OTCBB:APSN), Vernon Hills, Ill.   Business: Diagnostic, Neurology   Hired: Craig Taylor as president, CEO and a director, formerly partner of direct venture capital investments at Adams Street Partners LLC; he replaces...
07:00 , Aug 3, 2009 |  BC Week In Review  |  Clinical News

Applied NeuroSolutions preclinical data

Pooled data of serum samples from 2 trials showed that Applied NeuroSolutions' blood-based test for AD had >80% sensitivity and >70% specificity. Applied NeuroSolutions Inc. (OTCBB:APSN), Vernon Hills, Ill.   Product: Blood-based test for Alzheimer's...
07:00 , Sep 15, 2008 |  BC Week In Review  |  Company News

Applied NeuroSolutions diagnostic, neurology news

Applied NeuroSolutions hired William Blair & Co. LLC to explore strategic alternatives, including partnerships. The company markets P-Tau 231 for research use. The antibody-based test measures levels of phosphorylated tau (p-tau) 231 in cerebrospinal fluid...
08:00 , Dec 24, 2007 |  BC Week In Review  |  Clinical News

p-tau 231 ELISA test neurology data

In a retrospective analysis of 145 European subjects, CSF levels of p-tau 231 predicted whether a patient would convert to AD from MCI (p=0.001). The analysis included 43 MCI patients that converted to AD, 45...
08:00 , Dec 17, 2007 |  BC Week In Review  |  Company News

Applied NeuroSolutions board of directors update

Applied NeuroSolutions Inc. (APNS), Vernon Hills, Ill.   Business: Diagnostic, Neurology   Appointed: President and CEO Ellen Hoffing as chairman; she replaces Robert Vaters, who will remain a director  ...
07:00 , Oct 29, 2007 |  BC Week In Review  |  Company News

Applied NeuroSolutions board of directors update

Applied NeuroSolutions Inc. (APNS), Vernon Hills, Ill.   Business: Diagnostic, Neurology   Appointed: David Tiemeier, deputy director of the University of Chicago's office of technology and intellectual property  ...
08:00 , Dec 4, 2006 |  BC Week In Review  |  Company News

Applied NeuroSolutions, Eli Lilly deal

LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease (AD). LLY will have exclusive worldwide rights to APNS's IP related to the molecular neuropathology of AD as it pertains to the formation of...
02:18 , Nov 29, 2006 |  BC Extra  |  Company News

Eli Lilly, Applied NeuroSolutions in AD deal

LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease. LLY will have exclusive rights to APNS's IP related to the molecular neuropathology of AD as it pertains to the formation of neurofibrillary tangles....
07:00 , Sep 11, 2006 |  BC Week In Review  |  Company News

Applied NeuroSolutions board of directors update

Applied NeuroSolutions Inc. (APNS), Vernon Hills, Ill.   Business: Diagnostic, Neurology   Appointed: Alan Heller, an operating partner at Water Street Capital  ...